These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36173869)

  • 1. Reply to "Biologics Are Effective in the Management of Inflammatory Bowel Disease Following Liver Transplantation in Combination With Antirejection Therapy".
    Safarpour AR; Shojaei-Zarghani S; Mehrabi M; Keshtkar AA; Oroojan AA; Sivandzadeh GR
    Inflamm Bowel Dis; 2022 Dec; 28(12):e153. PubMed ID: 36173869
    [No Abstract]   [Full Text] [Related]  

  • 2. Biologics Are Effective in the Management of Inflammatory Bowel Disease Following Liver Transplantation in Combination With Antirejection Therapy.
    Vuyyuru SK; Brahmania M; Arab JP; Jairath V
    Inflamm Bowel Dis; 2022 Dec; 28(12):e150-e152. PubMed ID: 36173888
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety of Combination Biologic and Antirejection Therapy Post-Liver Transplantation in Patients With Inflammatory Bowel Disease.
    Al Draiweesh S; Ma C; Alkhattabi M; McDonald C; Nguyen TM; Beaton M; Chande N; Colquhoun P; Feagan BG; Gregor JC; Khanna R; Marotta P; Ponich T; Quan D; Qumosani K; Sandhu A; Sey M; Skaro A; Teriaky A; Wilson A; Yan B; Brahmania M; Jairath V
    Inflamm Bowel Dis; 2020 May; 26(6):949-959. PubMed ID: 31665288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel Disease.
    Peverelle M; Mills C; Testro A; Gow P; De Cruz P
    Inflamm Bowel Dis; 2020 Apr; 26(5):e35-e36. PubMed ID: 32076720
    [No Abstract]   [Full Text] [Related]  

  • 5. How to Manage Targeted Immune Suppressants (Biologics and Oral Small-molecule Drugs) Perioperatively for Inflammatory Bowel Disease and non-Inflammatory Bowel Disease surgery.
    Cohen BL; Lincango E; Holubar SD
    Clin Gastroenterol Hepatol; 2023 May; 21(5):1148-1151.e1. PubMed ID: 36934049
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-tumor necrosis factor therapy for inflammatory bowel disease in the setting of immunosuppression for solid organ transplantation.
    El-Nachef N; Terdiman J; Mahadevan U
    Am J Gastroenterol; 2010 May; 105(5):1210-1. PubMed ID: 20445523
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of Biologic Therapy in Liver Transplant Recipients: Case Closed?
    Davis BC
    Inflamm Bowel Dis; 2020 May; 26(6):960. PubMed ID: 31665307
    [No Abstract]   [Full Text] [Related]  

  • 8. Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease.
    Raffals LE; Nguyen GC; Rubin DT
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):818-823. PubMed ID: 30196164
    [No Abstract]   [Full Text] [Related]  

  • 9. Could small molecules be used in combination with biologics for inflammatory bowel disease?
    D'Amico F; Danese S; Fiorino G
    Expert Rev Clin Immunol; 2022 Oct; 18(10):991-993. PubMed ID: 35901521
    [No Abstract]   [Full Text] [Related]  

  • 10. Biologic drugs for inflammatory bowel disease.
    Yanai S; Matsumoto T
    Nihon Rinsho; 2017 Mar; 75(3):403-407. PubMed ID: 30566782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heading back to the trough (levels of biologics in IBD).
    Hanauer SB
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):548-51. PubMed ID: 25311382
    [No Abstract]   [Full Text] [Related]  

  • 12. Foreword. Biologics of IBD.
    Falk GW
    Gastroenterol Clin North Am; 2014 Sep; 43(3):xiii. PubMed ID: 25110263
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of biologics in pregnant, lactating patients with inflammatory bowel disease and the impact on neonatal vaccination: A systematic review of clinical practice guidelines and consensus statements.
    Ding N; Zhao L; Zhu L; Sun W; Li D; Li J; Zhang J; Zhang S
    J Clin Pharm Ther; 2022 Dec; 47(12):1952-1965. PubMed ID: 36452989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
    Goessens L; Colombel JF; Outtier A; Ferrante M; Sabino J; Judge C; Saeidi R; Rabbitt L; Armuzzi A; Domenech E; Michalopoulos G; Cremer A; García-Alonso FJ; Molnar T; Karmiris K; Gecse K; Van Oostrom J; Löwenberg M; Farkas K; Atreya R; Ribaldone DG; Selinger C; Hoentjen F; Bihin B; Sebastian S; ; Rahier JF
    United European Gastroenterol J; 2021 Dec; 9(10):1136-1147. PubMed ID: 34694746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of Intestinal Resection and Colectomy in Inflammatory Bowel Disease Patients After Initiation of Biologics: A Cohort Study.
    Khoudari G; Mansoor E; Click B; Alkhayyat M; Saleh MA; Sinh P; Katz J; Cooper GS; Regueiro M
    Clin Gastroenterol Hepatol; 2022 May; 20(5):e974-e983. PubMed ID: 33065311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical Therapy for Inflammatory Bowel Disease.
    Grevenitis P; Thomas A; Lodhia N
    Surg Clin North Am; 2015 Dec; 95(6):1159-82, vi. PubMed ID: 26596920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Managing inflammatory bowel disease in the biologics era: treating beyond symptoms is not sufficient].
    Peyrin-Biroulet L
    Rev Prat; 2014 Nov; 64(9):1207-9. PubMed ID: 25638855
    [No Abstract]   [Full Text] [Related]  

  • 18. Switching biologics used in inflammatory bowel diseases: how to deal with in practice?
    Liefferinckx C; Cremer A; Franchimont D
    Curr Opin Pharmacol; 2020 Dec; 55():82-89. PubMed ID: 33166871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Biologic Agents for the Management of Inflammatory Bowel Disease After Liver Transplantation.
    Shaikh SA; Fitzgerald L; Tischer S
    Pharmacotherapy; 2017 Dec; 37(12):1578-1585. PubMed ID: 28960437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis.
    Borren NZ; Ananthakrishnan AN
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1736-1743.e4. PubMed ID: 30616024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.